acute myocardial infarction
Conditions
Interventions
DAPA group:Dagliflozin 10mg per day was added to the standard treatment
DAPA-free group:standard treatment
Sponsors
The Second Affiliated Hospital of Anhui Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 90 Years
Inclusion criteria
Inclusion criteria: 1. Age 18-90 years; 2. All were diagnosed with ST-segment elevation myocardial infarction or non-ST-segment elevation myocardial infarction according to the guidelines; 3.
Exclusion criteria
Exclusion criteria: 1. pregnant or lactating women; 2. eGFR <45 mL/min/1.73 m2; 3. type 1 diabetes mellitus; 4. acute urinary tract infection or genital infection; 5. has a pacemaker; 6. persistent atrial fibrillation; 7. has not signed an informed consent form; 8. is currently on treatment with any SGLT-2 inhibitors; 9. Known allergy to SGLT-2 inhibitors
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cardiac autonomic function; | — |
Secondary
| Measure | Time frame |
|---|---|
| left ventricular remodeling index;Incidence of adverse cardiovascular events; | — |
Countries
China
Contacts
Public ContactJun Wan
The Second Affiliated Hospital of Anhui Medical University
Outcome results
None listed